Timothy M Mayleben - Net Worth and Insider Trading
Timothy M Mayleben Net Worth
The estimated net worth of Timothy M Mayleben is at least $533,232 dollars as of 2024-04-30. Timothy M Mayleben is the President and CEO of Vericel Corp and owns about 6,650 shares of Vericel Corp (VCEL) stock worth over $310,356. Timothy M Mayleben is the President & CEO of Esperion Therapeutics Inc and owns about 111,998 shares of Esperion Therapeutics Inc (ESPR) stock worth over $222,876. Timothy M Mayleben is also the Director of Loxo Oncology Inc and owns about 0 shares of Loxo Oncology Inc (LOXO) stock worth over $0. Details can be seen in Timothy M Mayleben's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Timothy M Mayleben has not made any transactions after 2020-03-11 and currently still holds the listed stock(s).
Transaction Summary of Timothy M Mayleben
Timothy M Mayleben Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy M Mayleben owns 6 companies in total, including Esperion Therapeutics Inc (ESPR) , Marinus Pharmaceuticals Inc (MRNS) , and Loxo Oncology Inc (LOXO) among others .
Click here to see the complete history of Timothy M Mayleben’s form 4 insider trades.
Insider Ownership Summary of Timothy M Mayleben
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2020-03-11 | director & Pres & Chief Executive Officer |
| MRNS | Marinus Pharmaceuticals Inc | 2014-07-31 | director |
| LOXO | Loxo Oncology Inc | 2019-02-15 | director |
| VCEL | Vericel Corp | 2011-08-08 | director & President and CEO |
| AKSY | Aksys Ltd | 2006-10-06 | director |
| LABP | Landos Biopharma Inc | 2021-05-13 | director |
Timothy M Mayleben Latest Holdings Summary
Timothy M Mayleben currently owns a total of 3 stocks. Among these stocks, Timothy M Mayleben owns 6,650 shares of Vericel Corp (VCEL) as of August 8, 2011, with a value of $310,356 and a weighting of 58.2%. Timothy M Mayleben owns 111,998 shares of Esperion Therapeutics Inc (ESPR) as of March 11, 2020, with a value of $222,876 and a weighting of 41.8%. Timothy M Mayleben also owns 0 shares of Loxo Oncology Inc (LOXO) as of June 8, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Timothy M Mayleben
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VCEL | Vericel Corp | 2011-08-08 | 6,650 | 46.67 | 310,356 |
| ESPR | Esperion Therapeutics Inc | 2020-03-11 | 111,998 | 1.99 | 222,876 |
| LOXO | Loxo Oncology Inc | 2018-06-08 | 0 | 234.66 | 0 |
Holding Weightings of Timothy M Mayleben
Timothy M Mayleben Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy M Mayleben has made a total of 0 transactions in Vericel Corp (VCEL) over the past 5 years. The most-recent trade in Vericel Corp is the acquisition of 500 shares on August 8, 2011, which cost Timothy M Mayleben around $21,100.
According to the SEC Form 4 filings, Timothy M Mayleben has made a total of 6 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 2,500 shares on March 11, 2020, which cost Timothy M Mayleben around $107,500.
According to the SEC Form 4 filings, Timothy M Mayleben has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 10,000 shares on June 8, 2018, which brought Timothy M Mayleben around $2 Million.
Insider Trading History of Timothy M Mayleben
- 1
Timothy M Mayleben Trading Performance
GuruFocus tracks the stock performance after each of Timothy M Mayleben's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy M Mayleben is 15.86%. GuruFocus also compares Timothy M Mayleben's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy M Mayleben within 3 months outperforms 14 times out of 20 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy M Mayleben's insider trading performs compared to the benchmark.
Performance of Timothy M Mayleben
Average Return
8.64%
Outperforming Transactions
32%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.25 | 15.86 | 5.21 | 8.64 | 0.83 | -30.64 |
| Relative Return to S&P 500(%) | 3.44 | 10.66 | -4.36 | -5.18 | -16.92 | -43.59 |
Timothy M Mayleben Ownership Network
Ownership Network List of Timothy M Mayleben
Ownership Network Relation of Timothy M Mayleben
Timothy M Mayleben Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Timothy M Mayleben is the director & Pres & Chief Executive Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Timothy M Mayleben made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,644 shares made by Eric Warren , a net sale of 9,821 shares made by Joanne M. Foody , and a net purchase of 7,560 shares made by Sheldon L. Koenig .
In summary, during the past 3 months, insiders sold 0 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,542 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 22,069 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Timothy M Mayleben Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy M Mayleben. You might contact Timothy M Mayleben via mailing address: 3621 South State St, 695 Kms Pl, Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
